Nova Leap Health Corp.

Nova Leap Health Corp.

NVLPF
Nova Leap Health Corp.US flagOther OTC
0.35
USD
+0.00
- -
30.92MMarket Cap

Total Valuation

Nova Leap Health Corp. carries a market capitalization of 30.92M, placing it among publicly traded companies globally. Its enterprise value stands at 24.53M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap30.92M
Enterprise Value24.53M

Share Statistics

Nova Leap Health Corp. currently has 87.31M shares outstanding.

Shares Outstanding87.31M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Nova Leap Health Corp. trades at a trailing price-to-earnings ratio of 15.98. The price-to-sales ratio is 0.64, and the price-to-book ratio stands at 1.11.

PE Ratio15.98
PS Ratio0.64
PB Ratio1.11
P/TBV Ratio-39.56
P/FCF Ratio10.58
P/OCF Ratio10.49

Enterprise Valuation

On an enterprise value basis, Nova Leap Health Corp. trades at an EV/EBITDA multiple of 9.89 and an EV/FCF ratio of 10.68. The EV/Sales ratio of 0.73 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.21 provides insight into valuation relative to core operating earnings.

EV / Sales0.73
EV / EBITDA9.89
EV / EBIT14.21
EV / FCF10.68

Financial Position

Nova Leap Health Corp. maintains a current ratio of 0.70, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 22.94, indicating elevated leverage, while an interest coverage ratio of 7.33 demonstrates adequate ability to service its debt obligations.

Current Ratio0.70
Quick Ratio0.63
Debt / Equity22.94
Debt / EBITDA1.80
Interest Coverage7.33

Financial Efficiency

Nova Leap Health Corp. posts a return on equity of 7.07 and a return on invested capital of 5.46.

Return on Equity (ROE)7.07
Return on Assets (ROA)5.45
Return on Invested Capital (ROIC)5.46
Return on Capital Employed (ROCE)6.95
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Over the trailing twelve months, Nova Leap Health Corp. has paid 513,977.00 in income taxes, reflecting an effective tax rate of 27.62.

Income Tax513,977.00
Effective Tax Rate27.62

Stock Price Statistics

Nova Leap Health Corp.'s stock has gained approximately 72.99463% over the past 52 weeks. The 50-day moving average sits at 0.37, while the 200-day moving average is 0.29.

Beta (5Y)N/A
52-Week Price Change72.99463%
50-Day Moving Average0.37
200-Day Moving Average0.29
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Nova Leap Health Corp. generated 33.60M in revenue and converted that into 1.35M in net income, yielding earnings per share of 0.02. EBITDA reached 2.48M, while operating income came in at 1.73M.

Revenue33.60M
Gross Profit13.41M
Operating Income1.73M
Pretax Income1.86M
Net Income1.35M
EBITDA2.48M
EBIT1.73M
Earnings Per Share (EPS)0.02

Balance Sheet

Nova Leap Health Corp. holds 1.44M in cash and equivalents against 4.45M in total debt, resulting in a net debt position of 2.00M. Total book value stands at 19.42M, with working capital of -1.64M providing operational flexibility.

Cash & Cash Equivalents1.44M
Total Debt4.45M
Net Debt2.00M
Equity (Book Value)19.42M
Book Value Per Share0.22
Working Capital-1.64M

Cash Flow

Nova Leap Health Corp. produced 2.05M in operating cash flow over the past twelve months.

Operating Cash Flow2.05M
Capital ExpendituresN/A
Free Cash Flow2.05M
FCF Per Share0.02

Margins

Nova Leap Health Corp. operates with a gross margin of 39.92, reflecting its pricing power and cost economics. The operating margin of 5.14 and net profit margin of 4.01 provide insight into operational efficiency.

Gross Margin39.92
Operating Margin5.14
Pretax Margin5.54
Profit Margin4.01
EBITDA Margin7.39

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-1.48
FCF Yield9.45

Scores

Nova Leap Health Corp. posts an Altman Z-Score of 8.40, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score8.40